Major Depressive Disorder
Showing NaN - NaN of 62
MDD Trial in United States (SAGE-217, Placebo)
Migraine, MDD Trial in Worldwide (Fremanezumab, Placebo)
Completed
- Migraine
- Major Depressive Disorder
- Fremanezumab
- Placebo
-
Little Rock, Arkansas
- +63 more
Dec 7, 2022
MDD Trial in United States (SP-624, Placebo)
Active, not recruiting
- Major Depressive Disorder
- SP-624
- Placebo
-
Phoenix, Arizona
- +38 more
May 13, 2022
MDD Trial in Worldwide (SPD489 (Lisdexamfetamine dimesylate) + Antidepressant)
Terminated
- Major Depressive Disorder
- SPD489 (Lisdexamfetamine dimesylate) + Antidepressant
-
Birmingham, Alabama
- +211 more
Jun 9, 2021
MDD Trial in United States (Antidepressant + SPD489 (lisdexamfetamine dimesylate), Antidepressant + )
Completed
- Major Depressive Disorder
- Antidepressant + SPD489 (lisdexamfetamine dimesylate)
- Antidepressant + placebo
-
Newport Beach, California
- +14 more
Jun 8, 2021
MDD Trial in United States (CP-601,927, Placebo)
MDD Trial in United States (Vortioxetine, Placebo)
MDD Trial in Puerto Rico, United States (Agomelatine (AGO178C), Placebo)
Completed
- Major Depressive Disorder
- Agomelatine (AGO178C)
- Placebo
-
Birmingham, Alabama
- +44 more
Dec 16, 2020
MDD Trial in Worldwide (MIN-117 5.0 mg, MIN-117 2.5 mg, Placebo)
Completed
- Major Depressive Disorder
- MIN-117 5.0 mg
- +2 more
-
Little Rock, Arkansas
- +46 more
Dec 14, 2020
Depression, MDD Trial in Canada, United States (Levomilnacipran ER, Placebo)
Completed
- Depression
- Major Depressive Disorder
- Levomilnacipran ER
- Placebo
-
Beverly Hills, California
- +34 more
Dec 23, 2019
MDD Trial in Puerto Rico, United States (Cariprazine, Antidepressant Therapy (ADT))
Completed
- Major Depressive Disorder
- Cariprazine
- Antidepressant Therapy (ADT)
-
Tucson, Arizona
- +89 more
Jul 29, 2019
MDD Trial in Worldwide (ALKS 5461, Placebo)
Completed
- Major Depressive Disorder
- ALKS 5461
- Placebo
-
Birmingham, Alabama
- +43 more
Aug 2, 2019
MDD Trial in Bulgaria, United States (ALKS 5461, Placebo)
Completed
- Major Depressive Disorder
- ALKS 5461
- Placebo
-
Little Rock, Arkansas
- +57 more
May 31, 2019
MDD Trial in United States (Antidepressant + , Antidepressant + cariprazine (0.1-0.3 mg/day), Antidepressant + cariprazine (1-2
Completed
- Major Depressive Disorder
- Antidepressant + placebo
- +2 more
-
Phoenix, Arizona
- +40 more
Feb 12, 2019
MDD Trial in Mexico, United States (desvenlafaxine succinate sustained release, fluoxetine, )
Completed
- Major Depressive Disorder
- desvenlafaxine succinate sustained release
- +2 more
-
Dothan, Alabama
- +42 more
Jan 2, 2019
MDD Trial in Worldwide (ALKS 5461)
Completed
- Major Depressive Disorder
- ALKS 5461
-
Birmingham, Alabama
- +157 more
Nov 21, 2018
MDD Trial in Worldwide (Placebo, Cariprazine)
Completed
- Major Depressive Disorder
- Placebo
- Cariprazine
-
Garden Grove, California
- +71 more
Mar 29, 2018
MDD Trial in United States (GLYX-13 5 mg/kg, GLYX-13 10 mg/kg, Placebo)
Completed
- Major Depressive Disorder
- GLYX-13 5 mg/kg
- +2 more
-
Birmingham, Alabama
- +25 more
Feb 18, 2016
MDD, Irritability Trial in United States (Brexpiprazole)
Completed
- Major Depressive Disorder
- Irritability
-
Tucson, Arizona
- +14 more
Feb 16, 2016